Capricor Therapeutics Stock Forecast
Volatile ride for Capricor Therapeutics stock price on Wednesday moving between $6.19 and $7.04
(Updated on Mar 27, 2024)
The Capricor Therapeutics stock price gained 7.29% on the last trading day (Wednesday, 27th Mar 2024), rising from $6.31 to $6.77. During the last trading day the stock fluctuated 13.73% from a day low at $6.19 to a day high of $7.04. The price has risen in 8 of the last 10 days and is up by 13.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 46 thousand more shares were traded than the day before. In total, 383 thousand shares were bought and sold for approximately $2.59 million.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $6.99 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 33.18% during the next 3 months and, with a 90% probability hold a price between $5.84 and $9.32 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CAPR Signals & Forecast
The Capricor Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.66 and $5.06. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -1.60%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Capricor Therapeutics stock
On the downside, the stock finds support just below today's level from accumulated volume at $6.38 and $5.89. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Capricor Therapeutics finds support just below today's level at $6.38. If this is broken, then the next support from accumulated volume will be at $5.89 and $5.80.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.85 between high and low, or 13.73%. For the last week, the stock has had daily average volatility of 10.18%.
Our recommended stop-loss: $6.50 (-4.03%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (CAPR) For The Upcoming Trading Day Of Thursday 28th
For the upcoming trading day on Thursday, 28th we expect Capricor Therapeutics to open at $6.67, and during the day (based on 14 day Average True Range), to move between $6.28 and $7.26, which gives a possible trading interval of +/-$0.493 (+/-7.29%) up or down from last closing price. If Capricor Therapeutics takes out the full calculated possible swing range there will be an estimated 14.57% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $6.79 (0.30%) than the support at $6.38 (5.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Capricor Therapeutics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Capricor Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 2.832 Buy Candidate Upgraded
Predicted Opening Price for Capricor Therapeutics of Thursday, March 28, 2024
Fair opening price March 28, 2024 | Current price |
---|---|
$6.67 ( 1.53%) | $6.77 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CAPR
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 7.52 | 11.03 % | |
R2 | 7.19 | 6.23 % | ||
R1 | 6.99 | 3.27 % | ||
Current price: | 6.77 | |||
Support | S1 | 6.34 | -6.32 % | |
S2 | 6.14 | -9.29 % | ||
S3 | 5.82 | -14.08 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 6.88 | 1.62 % | |
R2 | 6.85 | 1.18 % | ||
R1 | 6.79 | 0.295 % | ||
Current price | 6.77 | |||
Support | S1 | 6.38 | -5.76% | |
S2 | 5.89 | -13.00% | ||
S3 | 5.80 | -14.33% |
FAQ
Click here for our free guide on how to buy Capricor Therapeutics Stock.